| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
P7C3-A20
|
1235481-90-9 |
P7C3-A2
|
N-(3-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-2-FLUOROPROPYL)-3-METHOXYANILINE;3,6-二溴-BETA-氟-N-(3-甲氧基苯基)-9H-咔唑-9-丙胺;CS-2365
|
C22H19Br2FN2O |
506.205463 | |
|
STF-62247
|
315702-99-9 |
STF-62247
|
N-(3-甲基苯基)-4-(4-吡啶基)-1,3-噻唑-2-胺;N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺;STF-62247;STF62247;STF 62247;4-(吡啶-4-基)-N-(间甲苯基)噻唑-2-胺
|
C15H13N3S |
267.34882 | 631-141-1 |
|
Lanabecestat
|
1383982-64-6 |
AZD-3293
|
AZD-3293;CS-2359;AZD 3293;LY3314814;AZD-3293;LY 3314814
|
C26H28N4O |
412.52672 | 200-258-5 |
|
ZM 241385
|
139180-30-6 |
ZM 241385
|
ZM 241385;ZM241385;ZM-241385;CS-2353;4-(2-(7-氨基-2-(呋喃-2-基(-[1,2,4]三唑并[1,5-A][1,3,5]三嗪-5-氨基(乙基(苯酚
|
C16H15N7O2 |
337.34 | |
|
CP21R7
|
125314-13-8 |
CP21R7(CP21)
|
CS-2352;3-(3-氨基苯基)-4-(1-甲基-1H-吲哚-3-基)吡咯-2,5-二酮
|
C19H15N3O2 |
317.3413 | |
|
ARQ-092
|
1313881-70-7 |
ARQ-92
|
ARQ 092 Free Base;AKT inhibitor 2;3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine;ARQ-092;Miransertib
|
|||
|
BLU-554
|
1707289-21-1 |
BLU554
|
BLU-554;BLU 554;BLU554,CPDB0942;CS-2345;Tube948BLU667中间体(腾渤医药);N-((3S,4S)-3-((6-(2,6-二氯-3,5-二甲氧基苯基)喹唑啉-2-基)氨基)四氢-2H-吡喃-4-基)丙烯酰胺;BLU-554,一种有效的 FGFR4 抑制剂;TUBE948BLU667中间体;TUBE948BLU667中间体(腾渤医药)
|
C24H24Cl2N4O4 |
503.37776 | |
|
GSK2269557
|
1254036-71-9 |
CS-234
|
CS-2340;GSK 2269557;GSK-2269557
|
C26H28N6O |
440.55 | |
|
GSK-2881078
|
1539314-06-1 |
/
|
/;CS-2336;GSK2881078;GSK 2881078
|
C14H13F3N2O2S |
||
|
Ezutromid
|
945531-77-1 |
依珠曲米
|
SMT C1100;VOX C1100;BMN 195;SMT-C1100;VOX-C1100;BMN-195;BMN195;依珠曲米;CS-2334
|
C19H15NO3S |
337.3923 | |
|
FIIN-3
|
1637735-84-2 |
FIIN-3
|
FIIN3;FIIN 3;FIIN-3;CS-2331;FIIN3;FIIN 3
|
C34H36Cl2N8O4 |
691.60684 | |
|
tipifarnib
|
192185-72-1 |
替吡法尼
|
ZARNESTRA;IND 58359;R115777;IND-58359;IND58359;R-115777;R 115777;CS-2330;(R)-6-(氨基(4-氯苯基)(1-甲基-1H-咪唑-5-基)甲基)-4-(3-氯苯基)-1-甲基-2(2H)-喹啉酮;替吡法尼
|
C27H22Cl2N4O |
489.4 | |
|
Eluxadoline
|
864821-90-9 |
伊卢多啉
|
伊卢多啉;艾沙度林;CS-2329;依卢多啉;伊卡多啉
|
C32H35N5O5 |
569.6508 | 1592732-453-0 |
|
I-BRD9
|
1714146-59-4 |
GSK62
|
I-BRD9;I-brd9 GSK602;N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-di;5-Ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide
|
|||
|
BI-7273
|
1883429-21-7 |
CS-2327
|
CS-2327;BI 7273;BI7273
|
C20H23N3O3 |
353.41492 | |
|
CAMBENDAZOL
|
26097-80-3 |
坎苯达唑
|
(2-(4-噻唑基)-1-苯并咪唑5-基)氨基甲酸1-甲基乙基酯;坎苯达唑;坎苯哒唑;2-(4-噻唑基)-5-苯并咪唑氨基甲酸异丙酯;坎苯达唑(CAM);坎苯达唑 标准品;NSC377071;NOVAZOLE;MK 906;NOVIBEN;BONLAM
|
C14H14N4O2S |
302.35156 | 247-459-5 |
|
PRX08066
|
866206-55-5 |
PRX-866
|
CS-2323;5-[[4-[(6-氯噻吩并[2,3-D]嘧啶-4-基)氨基]-1-哌啶基]甲基]-2-氟-苯甲腈(2Z)-2-丁烯二酸盐
|
C23H21ClFN5O4S |
517.960343 | |
|
BAY 80-6946
|
1032568-63-0 |
BAY 8-6946 (Copanlisib)
|
2-氨基-N-[2,3-二氢-7-甲氧基-8-[3-(4-吗啉基)丙氧基]咪唑并[1,2-C]喹唑啉-5-基]-5-嘧啶甲酰胺;可泮利塞;CS-2321;库潘尼西;COPANLISIB,一种 ATP竞争性的选择性 I 型 PI3 激酶抑制剂
|
C23H28N8O4 |
480.51962 | |
|
RG2833
|
1215493-56-3 |
RG2833(RGFP19)
|
RG2833(RGFP109);N-[6-(2-氨基苯基氨基)-6-氧代己基]-4-甲基苯甲酰胺;RG2833;RGFP109;RG-2833;RGFP 109;CS-2320
|
C20H25N3O2 |
339.4314 | |
|
VU 0357017 hydrochloride
|
1135242-13-5 |
VU35717
|
|
C18H28ClN3O3 |
369.9 |
药智官方微信
药智官方微博
